EREG and atherosclerosis: EGFR ligands including heparin binding-EGF (HB-EGF)24, 25, epiregulin (EREG)26, TGF-α25, 27, and β-cellulin28 are associated with human atherosclerosis and potentially may contribute to the EGFR activation.